Anaïs Pujals

1.6k total citations
22 papers, 564 citations indexed

About

Anaïs Pujals is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Anaïs Pujals has authored 22 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 7 papers in Cancer Research. Recurrent topics in Anaïs Pujals's work include Cancer Genomics and Diagnostics (7 papers), Genetic factors in colorectal cancer (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Anaïs Pujals is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Genetic factors in colorectal cancer (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Anaïs Pujals collaborates with scholars based in France, United States and Switzerland. Anaïs Pujals's co-authors include Julien Caldéraro, Christophe Tournigand, Benoı̂t Rousseau, Alain Luciani, Jérémy Augustin, Philippe Compagnon, Daniel Cherqui, Jean–Michel Pawlotsky, Daniel Azoulay and Jacqueline Fontugne and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Surgical Pathology and Journal of Clinical Pathology.

In The Last Decade

Anaïs Pujals

22 papers receiving 558 citations

Peers

Countries citing papers authored by Anaïs Pujals

Since Specialization

Citations

This map shows the geographic impact of Anaïs Pujals's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anaïs Pujals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anaïs Pujals more than expected).

Fields of papers citing papers by Anaïs Pujals

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anaïs Pujals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anaïs Pujals. The network helps show where Anaïs Pujals may publish in the future.

Co-authorship network of co-authors of Anaïs Pujals

This figure shows the co-authorship network connecting the top 25 collaborators of Anaïs Pujals. A scholar is included among the top collaborators of Anaïs Pujals based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anaïs Pujals. Anaïs Pujals is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology 2024 ·npj Precision Oncology ·(unknown), (unknown), Zunamys I. Carrero, Chiara Maria Lavinia Loeffler, Marko van Treeck, Tanwei Yuan, Nicholas P. West, Philip Quirke, Titus J. Brinker, Hermann Brenner, (unknown), Bruno Märkl, Albrecht Stenzinger, Alexander Brobeil, Michael Hoffmeister, Julien Caldéraro, Anaïs Pujals, Jakob Nikolas Kather	10
2	Intentional R1 resection of liver metastases: A new treatment paradigm for patients with advanced colorectal cancer based on a propensity score–Matched case-control analysis 2023 ·Clinics and Research in Hepatology and Gastroenterology ·(unknown), (unknown), Étienne Audureau, Anaïs Pujals, (unknown), Alain Luciani, Julien Caldéraro, Danièle Sommacale, Gilles Châtellier, Christophe Tournigand, Alexis Laurent, Emmanuelle Kempf	2
3	Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection 2022 ·Molecular Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Aurélie Dupuy, Erell Guillerm, Philippe Gaulard, Orianne Wagner‐Ballon, Anaïs Pujals, Ivan Sloma	3
4	High prevalence of unusual KRAS , NRAS , and BRAF mutations in POLE ‐ hypermutated colorectal cancers 2022 ·Molecular Oncology ·(unknown), Justine V. Cohen, Julien Caldéraro, (unknown), (unknown), (unknown), (unknown), Aurélie Dupuy, (unknown), Emmanuèle Lechapt, Ivan Sloma, Christophe Tournigand, Benoı̂t Rousseau, Anaïs Pujals	2
5	Idylla MSI test as a new tool for microsatellite instability detection in sebaceous tumours and keratoacanthomas 2021 ·Journal of Clinical Pathology ·(unknown), (unknown), (unknown), Nicolás Ortonne, Anaïs Pujals	6
6	Detection of microsatellite instability in a panel of solid tumours with the Idylla MSI Test using extracted DNA 2020 ·Journal of Clinical Pathology ·(unknown), (unknown), Julien Caldéraro, Cécile Charpy, Jonathan Derman, Anaïs Pujals	27
7	The BCL‐2 family protein inhibitor ABT‐737 as an additional tool for the treatment of EBV‐associated post‐transplant lymphoproliferative disorders 2020 ·Molecular Oncology ·Aude Robert, Anaïs Pujals, (unknown), (unknown), Joëlle Wiels	14
8	Isolated 5′ Signals Are an Atypical Pattern To Be Considered as Positive for ALK Rearrangement: A Brief Report of Three Cases and Review of the Literature 2019 ·Translational Oncology ·Alice Guyard, Cécile Charpy, Nathalie Théou–Anton, (unknown), (unknown), (unknown), Karen Leroy, Anaïs Pujals, Christiane Copie‐Bergman, C. Chouaïd, Audrey Mansuet‐Lupo	4
9	Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study 2019 ·Lung Cancer ·(unknown), Jacques Cadranel, (unknown), Roger Lacave, Anaïs Pujals, Nicolas Girard, Céline Callens, V. Gounant, Nathalie Théou–Anton, S. Friard, Jean Trédaniel, Hélène Blons, C. Dujon, Boris Duchemann, Pierre Olivier Schischmanoff, Thierry Chinet, Etienne Giroux‐Leprieur	65
10	Evaluation of the Idylla system to detect the EGFR mutation using extracted DNA 2019 ·Pathology - Research and Practice ·(unknown), Justine V. Cohen, Romain Pelletier, Jeanne Tran Van Nhieu, Jonathan Derman, (unknown), (unknown), Isabelle Monnet, C. Chouaïd, Anaïs Pujals	18
11	Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing 2018 ·Journal of Molecular Diagnostics ·Aurélie Dupuy, François Lemonnier, Virginie Fataccioli, Nadine Martin‐Garcia, Cyrielle Robe, Romain Pelletier, Elsa Poullot, Anissa Moktefi, Karima Mokhtari, Marie Christine Rousselet, Alexandra Traverse‐Glehen, Richard Delarue, Olivier Tournilhac, Marie‐Hélène Delfau‐Larue, Corinne Haïoun, Nicolás Ortonne, Christiane Copie‐Bergman, Laurence de Leval, Anaïs Pujals, Philippe Gaulard	21
12	DNA degrades during storage in formalin-fixed and paraffin-embedded tissue blocks 2017 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·Alice Guyard, (unknown), Anaïs Pujals, Cyrielle Robe, Jeanne Tran Van Nhieu, Yves Allory, Julien Moroch, (unknown), Jean‐Christophe Fournet, Elie‐Serge Zafrani, Karen Leroy	78
13	Polymerase proofreading domain mutations: New opportunities for immunotherapy in hypermutated colorectal cancer beyond MMR deficiency 2017 ·Critical Reviews in Oncology/Hematology ·(unknown), Benoı̂t Rousseau, Anaïs Pujals, (unknown), Charlotte Joly, A Guillemin, Isabelle Baumgaertner, Cindy Neuzillet, Christophe Tournigand	57
14	PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma 2017 ·Oncotarget ·Jacqueline Fontugne, Jérémy Augustin, Anaïs Pujals, Philippe Compagnon, Benoı̂t Rousseau, Alain Luciani, Christophe Tournigand, Daniel Cherqui, Daniel Azoulay, Jean–Michel Pawlotsky, Julien Caldéraro	143
15	Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas 2017 ·The American Journal of Surgical Pathology ·(unknown), Aurélie Dupuy, Anaïs Pujals, Marie Parrens, B. Vergier, Alistair Robson, Marie‐Hélène Delfau‐Larue, S. Oro, O. Chosidow, Corinne Haïoun, M. Beylot‐Barry, Jean‐Philippe Merlio, Christiane Copie‐Bergman, Philippe Gaulard, Nicolás Ortonne	16
16	Adénocarcinome bronchique avec mutation de l’ EGFR et réarrangement ALK concomitants 2016 ·Revue des Maladies Respiratoires ·(unknown), I. Monnet, Anaïs Pujals, (unknown), (unknown), (unknown), Karen Leroy, C. Chouaïd	5
17	Constitutive autophagy contributes to resistance to TP53-mediated apoptosis in Epstein-Barr virus-positive latency III B-cell lymphoproliferations 2015 ·Autophagy ·Anaïs Pujals, (unknown), Catherine Pioche‐Durieu, Aude Robert, Guillaume Meurice, (unknown), (unknown), Nadine Martin‐Garcia, Éric Le Cam, Catherine Guettier, Martine Raphaël, Lyubomir T. Vassilev, Philippe Gaulard, Patrice Codogno, Marc Lipinski, Joëlle Wiels	29
18	Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1 2014 ·Bioorganic & Medicinal Chemistry Letters ·Sandy Desrat, Anaïs Pujals, Claire Colas, (unknown), (unknown), (unknown), (unknown), Bogdan I. Iorga, (unknown), Martine Raphaël, Joëlle Wiels, Fanny Roussi	9
19	Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis 2011 ·Cell Death and Disease ·Anaïs Pujals, (unknown), Aude Robert, (unknown), Émilie Hollville, Joëlle Wiels	14
20	Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein–Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells 2009 ·Leukemia ·(unknown), Émilie Hollville, Anaïs Pujals, Cécile Tétaud, (unknown), Joëlle Wiels	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact